|
|
Volumn 34, Issue 5, 2002, Pages 1913-1914
|
|
Can acute rejection be prevented in SPK transplantation?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN;
IMMUNOSUPPRESSIVE AGENT;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
RAPAMYCIN;
STEROID;
TACROLIMUS;
BIOAVAILABILITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FOLLOW UP;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
PANCREAS TRANSPLANTATION;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TRANSPLANTATION;
ACUTE DISEASE;
ARTICLE;
CHRONIC KIDNEY FAILURE;
COMPARATIVE STUDY;
DIABETIC NEPHROPATHY;
DRUG COMBINATION;
IMMUNOLOGY;
INSULIN DEPENDENT DIABETES MELLITUS;
KIDNEY TRANSPLANTATION;
MORTALITY;
SURVIVAL RATE;
TREATMENT OUTCOME;
ACUTE DISEASE;
COMPARATIVE STUDY;
DIABETES MELLITUS, INSULIN-DEPENDENT;
DIABETIC NEPHROPATHIES;
DRUG THERAPY, COMBINATION;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
PANCREAS TRANSPLANTATION;
SIROLIMUS;
SURVIVAL RATE;
TREATMENT OUTCOME;
DIABETES MELLITUS, TYPE 1;
HUMANS;
|
|
EID: 0035993805
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03149-4 Document Type: Conference Paper |
|
Times cited : (22)
|
|
References (6)
|
